 | • レポートコード：MRC2-11QY12034 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがん治療におけるゲノミクスのグローバル市場について調査・分析したレポートです。種類別（機器、消耗品、サービス）市場規模、用途別（診断、個別化医療、創薬、開発、研究）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がん治療におけるゲノミクスの競争状況、市場シェア ・世界のがん治療におけるゲノミクス市場：種類別市場規模 2015年-2020年（機器、消耗品、サービス） ・世界のがん治療におけるゲノミクス市場：種類別市場規模予測 2021年-2026年（機器、消耗品、サービス） ・世界のがん治療におけるゲノミクス市場：用途別市場規模 2015年-2020年（診断、個別化医療、創薬、開発、研究） ・世界のがん治療におけるゲノミクス市場：用途別市場規模予測 2021年-2026年（診断、個別化医療、創薬、開発、研究） ・北米のがん治療におけるゲノミクス市場分析：米国、カナダ ・ヨーロッパのがん治療におけるゲノミクス市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがん治療におけるゲノミクス市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがん治療におけるゲノミクス市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがん治療におけるゲノミクス市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Illumina、Thermo Fisher scientific、Agilent、Roche、Cancer Genetics、Beckman Coulter、Bio-Rad、Danaher、Sigma Aldrich、Pacific Biosciences、Quest Diagnostics、Luminex、Oxford Gene Technology、PerkinElmer、Qiagen、GE Healthcare、Thermo Fisher scientific ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Use genomic knowledge to keep prevention of cancer
Growing demand for diagnostics coupled with availability of technologically advanced and cost efficient diagnostic technology is expected to fuel the market growth in coming years.
Market Analysis and Insights: Global Genomics In Cancer Care Market
The global Genomics In Cancer Care market size is projected to reach US$ 17170 million by 2026, from US$ 15520 million in 2020, at a CAGR of 9.8%% during 2021-2026.
Global Genomics In Cancer Care Scope and Market Size
Genomics In Cancer Care market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genomics In Cancer Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Illumina
Thermo Fisher scientific
Agilent
Roche
Cancer Genetics
Beckman Coulter
Bio-Rad
Danaher
Sigma Aldrich
Pacific Biosciences
Quest Diagnostics
Luminex
Oxford Gene Technology
PerkinElmer
Qiagen
GE Healthcare
Thermo Fisher scientific
Market segment by Type, the product can be split into
Instruments
Consumables
Services
Market segment by Application, split into
Diagnostics
Personalized Medicine
Drug Discovery
Development
Research
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
1.4 Market by Type
1.4.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Consumables
1.4.4 Services
1.5 Market by Application
1.5.1 Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Personalized Medicine
1.5.4 Drug Discovery
1.5.5 Development
1.5.6 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2015-2026)
2.2 Global Genomics In Cancer Care Growth Trends by Regions
2.2.1 Genomics In Cancer Care Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genomics In Cancer Care Historic Market Share by Regions (2015-2020)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genomics In Cancer Care Market Growth Strategy
2.3.6 Primary Interviews with Key Genomics In Cancer Care Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Market Size
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2015-2020)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2015-2020)
3.1.3 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genomics In Cancer Care Market Concentration Ratio
3.2.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2019
3.3 Genomics In Cancer Care Key Players Head office and Area Served
3.4 Key Players Genomics In Cancer Care Product Solution and Service
3.5 Date of Enter into Genomics In Cancer Care Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2015-2020)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Genomics In Cancer Care Market Size by Application (2015-2020)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2015-2020)
6.2 Genomics In Cancer Care Key Players in North America (2019-2020)
6.3 North America Genomics In Cancer Care Market Size by Type (2015-2020)
6.4 North America Genomics In Cancer Care Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2015-2020)
7.2 Genomics In Cancer Care Key Players in Europe (2019-2020)
7.3 Europe Genomics In Cancer Care Market Size by Type (2015-2020)
7.4 Europe Genomics In Cancer Care Market Size by Application (2015-2020)
8 China
8.1 China Genomics In Cancer Care Market Size (2015-2020)
8.2 Genomics In Cancer Care Key Players in China (2019-2020)
8.3 China Genomics In Cancer Care Market Size by Type (2015-2020)
8.4 China Genomics In Cancer Care Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genomics In Cancer Care Market Size (2015-2020)
9.2 Genomics In Cancer Care Key Players in Japan (2019-2020)
9.3 Japan Genomics In Cancer Care Market Size by Type (2015-2020)
9.4 Japan Genomics In Cancer Care Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genomics In Cancer Care Market Size (2015-2020)
10.2 Genomics In Cancer Care Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020)
10.4 Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020)
11 India
11.1 India Genomics In Cancer Care Market Size (2015-2020)
11.2 Genomics In Cancer Care Key Players in India (2019-2020)
11.3 India Genomics In Cancer Care Market Size by Type (2015-2020)
11.4 India Genomics In Cancer Care Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genomics In Cancer Care Market Size (2015-2020)
12.2 Genomics In Cancer Care Key Players in Central & South America (2019-2020)
12.3 Central & South America Genomics In Cancer Care Market Size by Type (2015-2020)
12.4 Central & South America Genomics In Cancer Care Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview
13.1.3 Illumina Genomics In Cancer Care Introduction
13.1.4 Illumina Revenue in Genomics In Cancer Care Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Thermo Fisher scientific
13.2.1 Thermo Fisher scientific Company Details
13.2.2 Thermo Fisher scientific Business Overview
13.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
13.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
13.2.5 Thermo Fisher scientific Recent Development
13.3 Agilent
13.3.1 Agilent Company Details
13.3.2 Agilent Business Overview
13.3.3 Agilent Genomics In Cancer Care Introduction
13.3.4 Agilent Revenue in Genomics In Cancer Care Business (2015-2020)
13.3.5 Agilent Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Genomics In Cancer Care Introduction
13.4.4 Roche Revenue in Genomics In Cancer Care Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Cancer Genetics
13.5.1 Cancer Genetics Company Details
13.5.2 Cancer Genetics Business Overview
13.5.3 Cancer Genetics Genomics In Cancer Care Introduction
13.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020)
13.5.5 Cancer Genetics Recent Development
13.6 Beckman Coulter
13.6.1 Beckman Coulter Company Details
13.6.2 Beckman Coulter Business Overview
13.6.3 Beckman Coulter Genomics In Cancer Care Introduction
13.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020)
13.6.5 Beckman Coulter Recent Development
13.7 Bio-Rad
13.7.1 Bio-Rad Company Details
13.7.2 Bio-Rad Business Overview
13.7.3 Bio-Rad Genomics In Cancer Care Introduction
13.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020)
13.7.5 Bio-Rad Recent Development
13.8 Danaher
13.8.1 Danaher Company Details
13.8.2 Danaher Business Overview
13.8.3 Danaher Genomics In Cancer Care Introduction
13.8.4 Danaher Revenue in Genomics In Cancer Care Business (2015-2020)
13.8.5 Danaher Recent Development
13.9 Sigma Aldrich
13.9.1 Sigma Aldrich Company Details
13.9.2 Sigma Aldrich Business Overview
13.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
13.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020)
13.9.5 Sigma Aldrich Recent Development
13.10 Pacific Biosciences
13.10.1 Pacific Biosciences Company Details
13.10.2 Pacific Biosciences Business Overview
13.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
13.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020)
13.10.5 Pacific Biosciences Recent Development
13.11 Quest Diagnostics
10.11.1 Quest Diagnostics Company Details
10.11.2 Quest Diagnostics Business Overview
10.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
10.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020)
10.11.5 Quest Diagnostics Recent Development
13.12 Luminex
10.12.1 Luminex Company Details
10.12.2 Luminex Business Overview
10.12.3 Luminex Genomics In Cancer Care Introduction
10.12.4 Luminex Revenue in Genomics In Cancer Care Business (2015-2020)
10.12.5 Luminex Recent Development
13.13 Oxford Gene Technology
10.13.1 Oxford Gene Technology Company Details
10.13.2 Oxford Gene Technology Business Overview
10.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
10.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020)
10.13.5 Oxford Gene Technology Recent Development
13.14 PerkinElmer
10.14.1 PerkinElmer Company Details
10.14.2 PerkinElmer Business Overview
10.14.3 PerkinElmer Genomics In Cancer Care Introduction
10.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020)
10.14.5 PerkinElmer Recent Development
13.15 Qiagen
10.15.1 Qiagen Company Details
10.15.2 Qiagen Business Overview
10.15.3 Qiagen Genomics In Cancer Care Introduction
10.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2015-2020)
10.15.5 Qiagen Recent Development
13.16 GE Healthcare
10.16.1 GE Healthcare Company Details
10.16.2 GE Healthcare Business Overview
10.16.3 GE Healthcare Genomics In Cancer Care Introduction
10.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020)
10.16.5 GE Healthcare Recent Development
13.17 Thermo Fisher scientific
10.17.1 Thermo Fisher scientific Company Details
10.17.2 Thermo Fisher scientific Business Overview
10.17.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
10.17.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
10.17.5 Thermo Fisher scientific Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Genomics In Cancer Care Key Market Segments
Table 2. Key Players Covered: Ranking by Genomics In Cancer Care Revenue
Table 3. Ranking of Global Top Genomics In Cancer Care Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instruments
Table 6. Key Players of Consumables
Table 7. Key Players of Services
Table 8. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Genomics In Cancer Care Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Genomics In Cancer Care Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Genomics In Cancer Care Market Share by Regions (2015-2020)
Table 12. Global Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Genomics In Cancer Care Market Growth Strategy
Table 18. Main Points Interviewed from Key Genomics In Cancer Care Players
Table 19. Global Genomics In Cancer Care Revenue by Players (2015-2020) (Million US$)
Table 20. Global Genomics In Cancer Care Market Share by Players (2015-2020)
Table 21. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019)
Table 22. Global Genomics In Cancer Care by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Genomics In Cancer Care Product Solution and Service
Table 25. Date of Enter into Genomics In Cancer Care Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 28. Global Genomics In Cancer Care Market Size Share by Type (2015-2020)
Table 29. Global Genomics In Cancer Care Revenue Market Share by Type (2021-2026)
Table 30. Global Genomics In Cancer Care Market Size Share by Application (2015-2020)
Table 31. Global Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 32. Global Genomics In Cancer Care Market Size Share by Application (2021-2026)
Table 33. North America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 35. North America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 36. North America Genomics In Cancer Care Market Share by Type (2015-2020)
Table 37. North America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 38. North America Genomics In Cancer Care Market Share by Application (2015-2020)
Table 39. Europe Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 41. Europe Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Genomics In Cancer Care Market Share by Type (2015-2020)
Table 43. Europe Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Genomics In Cancer Care Market Share by Application (2015-2020)
Table 45. China Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 46. China Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 47. China Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 48. China Genomics In Cancer Care Market Share by Type (2015-2020)
Table 49. China Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 50. China Genomics In Cancer Care Market Share by Application (2015-2020)
Table 51. Japan Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 53. Japan Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Genomics In Cancer Care Market Share by Type (2015-2020)
Table 55. Japan Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Genomics In Cancer Care Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 59. Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Genomics In Cancer Care Market Share by Type (2015-2020)
Table 61. Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Genomics In Cancer Care Market Share by Application (2015-2020)
Table 63. India Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 64. India Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 65. India Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 66. India Genomics In Cancer Care Market Share by Type (2015-2020)
Table 67. India Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 68. India Genomics In Cancer Care Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 71. Central & South America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Genomics In Cancer Care Market Share by Type (2015-2020)
Table 73. Central & South America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Genomics In Cancer Care Market Share by Application (2015-2020)
Table 75. Illumina Company Details
Table 76. Illumina Business Overview
Table 77. Illumina Product
Table 78. Illumina Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 79. Illumina Recent Development
Table 80. Thermo Fisher scientific Company Details
Table 81. Thermo Fisher scientific Business Overview
Table 82. Thermo Fisher scientific Product
Table 83. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 84. Thermo Fisher scientific Recent Development
Table 85. Agilent Company Details
Table 86. Agilent Business Overview
Table 87. Agilent Product
Table 88. Agilent Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 89. Agilent Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Cancer Genetics Company Details
Table 96. Cancer Genetics Business Overview
Table 97. Cancer Genetics Product
Table 98. Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 99. Cancer Genetics Recent Development
Table 100. Beckman Coulter Company Details
Table 101. Beckman Coulter Business Overview
Table 102. Beckman Coulter Product
Table 103. Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 104. Beckman Coulter Recent Development
Table 105. Bio-Rad Company Details
Table 106. Bio-Rad Business Overview
Table 107. Bio-Rad Product
Table 108. Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 109. Bio-Rad Recent Development
Table 110. Danaher Business Overview
Table 111. Danaher Product
Table 112. Danaher Company Details
Table 113. Danaher Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 114. Danaher Recent Development
Table 115. Sigma Aldrich Company Details
Table 116. Sigma Aldrich Business Overview
Table 117. Sigma Aldrich Product
Table 118. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 119. Sigma Aldrich Recent Development
Table 120. Pacific Biosciences Company Details
Table 121. Pacific Biosciences Business Overview
Table 122. Pacific Biosciences Product
Table 123. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 124. Pacific Biosciences Recent Development
Table 125. Quest Diagnostics Company Details
Table 126. Quest Diagnostics Business Overview
Table 127. Quest Diagnostics Product
Table 128. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 129. Quest Diagnostics Recent Development
Table 130. Luminex Company Details
Table 131. Luminex Business Overview
Table 132. Luminex Product
Table 133. Luminex Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 134. Luminex Recent Development
Table 135. Oxford Gene Technology Company Details
Table 136. Oxford Gene Technology Business Overview
Table 137. Oxford Gene Technology Product
Table 138. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 139. Oxford Gene Technology Recent Development
Table 140. PerkinElmer Company Details
Table 141. PerkinElmer Business Overview
Table 142. PerkinElmer Product
Table 143. PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 144. PerkinElmer Recent Development
Table 145. Qiagen Company Details
Table 146. Qiagen Business Overview
Table 147. Qiagen Product
Table 148. Qiagen Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 149. Qiagen Recent Development
Table 150. GE Healthcare Company Details
Table 151. GE Healthcare Business Overview
Table 152. GE Healthcare Product
Table 153. GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 154. GE Healthcare Recent Development
Table 155. Thermo Fisher scientific Company Details
Table 156. Thermo Fisher scientific Business Overview
Table 157. Thermo Fisher scientific Product
Table 158. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 159. Thermo Fisher scientific Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Market Share by Type: 2020 VS 2026
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Services Features
Figure 5. Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
Figure 6. Diagnostics Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Development Case Studies
Figure 10. Research Case Studies
Figure 11. Genomics In Cancer Care Report Years Considered
Figure 12. Global Genomics In Cancer Care Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Genomics In Cancer Care Market Share by Regions: 2020 VS 2026
Figure 14. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Genomics In Cancer Care Market Share by Players in 2019
Figure 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2019
Figure 19. North America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
ゲノミクスの世界市場（～2026年） Genomics is the science of studying genomes and their interaction with a variety of stimuli. The global genomics market is chiefly driven by the intensifying level of competition in the global pharmaceutical industry and the increased use of genomics in research and development of new drug classes. …- ゲノミクスパーソナライズドヘルスの世界市場（～2026年） The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in em…
- 大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…
- ゲノミクス・プロテオミクス試薬・研究キット・分析機器の世界市場（～2026年） The market is segmented into two major areas, namely, the genomics and proteomics reagent kits market and the genomics and proteomics analytical tools market. The reagent and research kits segment deals with the products used in sample preparation, purification and isolation, electrophoresis, lab-on…
- がん検診/スクリーニングの世界市場（～2026年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…